Imatinib and GNF-5 Exhibit an Inhibitory Effect on Growth of Hepatocellar Carcinoma Cells by Downregulating S-phase Kinase-associated Protein 2

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and is one of the leading causes of cancer-related deaths worldwide. Imatinib and GNF-5 are breakpoint cluster region-Abelson murine leukemia tyrosine kinase inhibitors which have been approved for the treatment of chronic myeloi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Haibo, Yi, Junkoo, Yoon, Duhak, Ryoo, Zaeyoung, Lee, Inkyu, Kim, Myoungok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Cancer Prevention 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783238/
https://www.ncbi.nlm.nih.gov/pubmed/33409258
http://dx.doi.org/10.15430/JCP.2020.25.4.252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783238/
https://www.ncbi.nlm.nih.gov/pubmed/33409258
http://dx.doi.org/10.15430/JCP.2020.25.4.252

Ejemplares similares